242 related articles for article (PubMed ID: 2002334)
1. Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line.
Lukas RJ
J Neurochem; 1991 Apr; 56(4):1134-45. PubMed ID: 2002334
[TBL] [Abstract][Full Text] [Related]
2. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors.
Gentry CL; Wilkins LH; Lukas RJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):206-16. PubMed ID: 12490593
[TBL] [Abstract][Full Text] [Related]
3. Interactions between tachykinins and diverse, human nicotinic acetylcholine receptor subtypes.
Lukas RJ; Eisenhour CM
Neurochem Res; 1996 Oct; 21(10):1245-57. PubMed ID: 8923487
[TBL] [Abstract][Full Text] [Related]
4. Two components of carbamylcholine-induced loss of nicotinic acetylcholine receptor function in the neuronal cell line PC12.
Simasko SM; Soares JR; Weiland GA
Mol Pharmacol; 1986 Jul; 30(1):6-12. PubMed ID: 3724745
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma.
Lukas RJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):175-82. PubMed ID: 2571716
[TBL] [Abstract][Full Text] [Related]
6. Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line.
Lukas RJ
J Pharmacol Exp Ther; 1993 Apr; 265(1):294-302. PubMed ID: 8474012
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment.
Ke L; Eisenhour CM; Bencherif M; Lukas RJ
J Pharmacol Exp Ther; 1998 Aug; 286(2):825-40. PubMed ID: 9694939
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers.
Daly JW; Nishizawa Y; Edwards MW; Waters JA; Aronstam RS
Neurochem Res; 1991 Apr; 16(4):489-500. PubMed ID: 1922660
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic agonists regulate alpha-bungarotoxin binding sites of TE671 human medulloblastoma cells.
Siegel HN; Lukas RJ
J Neurochem; 1988 Apr; 50(4):1272-8. PubMed ID: 3346679
[TBL] [Abstract][Full Text] [Related]
10. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Rollema H; Hurst RS
Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
[TBL] [Abstract][Full Text] [Related]
11. Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure.
Reitstetter R; Lukas RJ; Gruener R
J Pharmacol Exp Ther; 1999 May; 289(2):656-60. PubMed ID: 10215636
[TBL] [Abstract][Full Text] [Related]
12. Neuronal-like features of TE671 cells: presence of a functional nicotinic cholinergic receptor.
Syapin PJ; Salvaterra PM; Engelhardt JK
Brain Res; 1982 Jan; 231(2):365-77. PubMed ID: 7055685
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line.
Zhao L; Kuo YP; George AA; Peng JH; Purandare MS; Schroeder KM; Lukas RJ; Wu J
J Pharmacol Exp Ther; 2003 Jun; 305(3):1132-41. PubMed ID: 12626641
[TBL] [Abstract][Full Text] [Related]
14. Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: a possible functional role of the cytoskeleton.
Bencherif M; Lukas RJ
J Neurochem; 1993 Sep; 61(3):852-64. PubMed ID: 8360687
[TBL] [Abstract][Full Text] [Related]
15. Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor of PC12 cells.
Robinson D; McGee R
Mol Pharmacol; 1985 Apr; 27(4):409-17. PubMed ID: 3982388
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic acetylcholine receptor antagonists alter the function and expression of serine racemase in PC-12 and 1321N1 cells.
Singh NS; Paul RK; Ramamoorthy A; Torjman MC; Moaddel R; Bernier M; Wainer IW
Cell Signal; 2013 Dec; 25(12):2634-45. PubMed ID: 24012499
[TBL] [Abstract][Full Text] [Related]
17. Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure.
Gentry CL; Lukas RJ
Curr Drug Targets CNS Neurol Disord; 2002 Aug; 1(4):359-85. PubMed ID: 12769610
[TBL] [Abstract][Full Text] [Related]
18. Release of (3H)norepinephrine from a clonal line of pheochromocytoma cells (PC12) by nicotinic cholinergic stimulation.
Greene LA; Rein G
Brain Res; 1977 Dec; 138(3):521-8. PubMed ID: 597722
[TBL] [Abstract][Full Text] [Related]
19. RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.
Bencherif M; Lovette ME; Fowler KW; Arrington S; Reeves L; Caldwell WS; Lippiello PM
J Pharmacol Exp Ther; 1996 Dec; 279(3):1413-21. PubMed ID: 8968366
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
Jonnala RR; Buccafusco JJ
J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
